It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Production of biopharmaceuticals relies on the expression of mammalian cDNAs in host organisms. Here we show that the expression of a human cDNA in the moss Physcomitrium patens generates the expected full-length and four additional transcripts due to unexpected splicing. This mRNA splicing results in non-functional protein isoforms, cellular misallocation of the proteins and low product yields. We integrated these results together with the results of our analysis of all 32,926 protein-encoding Physcomitrella genes and their 87,533 annotated transcripts in a web application, physCO, for automatized optimization. A thus optimized cDNA results in about twelve times more protein, which correctly localizes to the ER. An analysis of codon preferences of different production hosts suggests that similar effects occur also in non-plant hosts. We anticipate that the use of our methodology will prevent so far undetected mRNA heterosplicing resulting in maximized functional protein amounts for basic biology and biotechnology.
Top et al. report the expression of a human blood-clotting factor IX-encoding cDNA in the moss Physcomitrium patens and demonstrate that in addition to the unspliced full-length transcript, the splicing machinery produced several different transcripts, and thus different protein isoforms, which the authors designate as heterosplicing. The authors present a web application, physCO, to automatize the process of P. patens-specific codon optimization, a tool that can assist in maximized functional protein amounts for biotechnology.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details







1 University of Freiburg, Plant Biotechnology, Faculty of Biology, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Spemann Graduate School of Biology and Medicine (SGBM), Freiburg, Germany (GRID:grid.5963.9); Ludwig-Maximilians-University Munich, Plant Molecular Cell Biology, Department Biology I, LMU Biocenter, Planegg-Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X)
2 University of Freiburg, Plant Biotechnology, Faculty of Biology, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Cluster of Excellence livMatS @ FIT – Freiburg Center for Interactive Materials and Bioinspired Technologies, Freiburg, Germany (GRID:grid.5963.9)
3 University of Freiburg, Plant Biotechnology, Faculty of Biology, Freiburg, Germany (GRID:grid.5963.9)
4 University of Freiburg, Plant Biotechnology, Faculty of Biology, Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Spemann Graduate School of Biology and Medicine (SGBM), Freiburg, Germany (GRID:grid.5963.9); University of Freiburg, Cluster of Excellence livMatS @ FIT – Freiburg Center for Interactive Materials and Bioinspired Technologies, Freiburg, Germany (GRID:grid.5963.9); CIBSS – Centre for Integrative Biological Signalling Studies, Freiburg, Germany (GRID:grid.5963.9)